Guillaume Fournié and Dr Javier Guitian from the Royal Veterinary College - working with colleagues from the London School of Hygiene and Tropical Medicine and Imperial College - have developed a model to understand how live bird markets act as a "hub" of infection for domestic poultry and if rest days, during which such markets are emptied and disinfected, may reduce transmission.
The results are published today in Interface - the Journal of The Royal Society. PhD student Guillaume Fournié, who led the research, said: "Live bird markets can be a reservoir of infection for domestic poultry and may therefore be responsible for sustaining H5N1 HPAI virus circulation.
"Compared to interventions applied in farms - such as stamping out and vaccination - our model shows that frequent rest days are an effective means with which to reduce H5N1 HPAI infection rates. Furthermore, our model predicts that full market closure - as has been implemented in some countries such as Egypt and Vietnam - would only be slightly more effective than rest days to reduce transmission of the disease."
The models used in the study are based on the live bird market chain in Hong Kong and the analysis restricted to chickens. Fournié, who qualified to be a vet in Alfort in his native France, was awarded fully-funded studentships (tuition fees and a living allowance) in 2007 by The Bloomsbury Colleges - a consortium of six colleges of the University of London: Birkbeck, IoE, LSHTM, RVC, School of Oriental and African Studies, and The School of Pharmacy - to conduct the research.
Since December 2003 outbreaks of H5N1 Highly Pathogenic Avian Influenza (HPA1) affecting domestic poultry have been reported in 50 countries across the world. Massive economic losses and the pandemic threat make H5N1 HPAI one of the greatest current public health concerns.
A full copy of the report can be seen in Interface at http://rsif.royalsocietypublishing.org
Dechra Pharmaceuticals PLC has announced that it has acquired the entire issued share capital of Genitrix Limited ("Genitrix") from its owner managers for an initial cash consideration of £5.4 million, with a further £0.8 million being payable upon achievement of specific milestones.
Dechra says the acquisition of Genitrix is consistent with its strategy to grow its international veterinary pharmaceutical business. In the year ended 31 March 2010, Genitrix achieved revenues of £2.4 million.
Ian Page, Chief Executive of Dechra, said: "Genitrix range of equine and companion animal products enhances and complements our UK product portfolio. Furthermore the recently approved canine epilepsy product, Libromide, provides future growth opportunities through potential mutual recognition in Europe. The acquisition is expected to be earnings enhancing in the first full year following ownership."
A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health.
In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.
Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.
Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".
The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.
The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.
In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.
Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.
*ReferenceSchmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651
Intervet/Schering-Plough Animal Health has announced that Metricure is now back in stock and available from the veterinary wholesalers with immediate effect.
Metricure is the only licensed intra-uterine antibiotic for the treatment of endometritis and is specially designed for the anaerobic intra-uterine environment.
The company would like to thank the profession for its patience and understanding, and looks forward to supporting vets striving to improve fertility on clients' farms.
Please contact the Intervet/Schering-Plough Veterinary Support Group on 01908 685685 if you require any further information.
Dechra Veterinary Products has launched the first in a series of 'How To' videos for pet owners which are now available online at dechra.co.uk and via youtube
In the videos, Louise O'Dwyer, Head Nurse at Petmedics in Manchester demonstrates how pet owners can complete simple tasks to look after their animals.
Carol Morgan, Product Manager at Dechra, said: "The feedback we get from vets suggests that pet owners would welcome advice and guidance on how to complete simple tasks. Many owners have a fear of getting it wrong so just don't do it. For example, when it comes to cleaning their pets ears, owners are concerned that it could be difficult to do or that they may hurt their pet. As these simple tasks are very important to the health of all pets, we decided to produce the videos as helpful tools for pet owners. They show owners what to do in easy to follow steps. By effectively carrying out these procedures, owners can also reduce the risk of their pet having problems in the future."
In addition to "How To Shampoo Your Dog" and "How To Pill A Cat", "How To Clean A Dog's Ears" and "How To Clean A Cat's Ears" will be available shortly.
Louise O'Dwyer, Head Nurse at Petmedics in Manchester, added: "To us it is quite straightforward but any of the four activities we have focused on can be quite stressful for pet owners. If anyone has ever had to give a pill to a cat, they will know how difficult this can be. The videos are simple to follow and demonstrate how to complete each task, with clear verbal instructions. We really hope this will help to overcome some of the fears and help pet owners in looking after their pets."
Incidentally, if your own practice website is short on video content, you might like to consider adding (or 'embedding') the videos on your site. Because they are hosted on youtube, it is very simple to do, even DIY.
William McEwan BSc MRes PhD, now working at the MRC-Laboratory of Molecular Biology in Cambridge, has been awarded the ABCD and Merial Young Scientist of the Year Award 2010 for his work on the replication and cross-species transmission of feline immunodeficiency virus infection in domestic cats and lions, and the restriction factors in these species in particular.
Dr McEwan said: "Understanding the means by which host species are able to prevent viral replication gives us insight to the mechanisms of infection and may allow us to engineer therapy based on similar mechanisms or by enhancing immune responses."
The award was presented by Professor Marian C. Horzinek, Chair of the European Advisory Board on Cat Diseases (ABCD) and of the award jury. He said: "William McEwan presented a very original, high quality paper. His research has indicated the ability of hosts to potently restrict retroviral replication - given sufficient evolutionary time. It has also highlighted felids as a taxon that is potentially highly prone to cross-species transmission of immunodeficiency viruses".
The ABCD and Merial Young Scientist Award, created in 2008 and worth 1000 €, is funded by Merial and is presented to a young scientist in veterinary or biomedical science, who has made an original contribution in the field of feline infectious diseases and/or immunology. Applicants should have published their findings in a journal listed in PubMed or Web of Science or have had them accepted by another recognised assessing body.
Candidates should be based in Europe, have completed a veterinary or biomedical curriculum, and be under 35 years of age at the time of application. Applications for the 2011 award are now being invited (deadline 15 January 2011). For more information, visit: www.abcd-vets.org
Bayer Animal Health has announced that its parasiticide - Advocate Spot-On Solution - is now licensed to be used weekly, and for a prolonged period of time, in severe cases of demodicosis in dogs.
According to the company, recent work carried out to obtain the new weekly indication shows a number of benefits of this increased application frequency for severely affected animals. Dogs treated on a weekly basis showed a greater reduction in mite numbers, fewer clinical signs, and improved hair regrowth and weight gain over the trial period, when compared to dogs treated monthly.
Advocate remains licensed for monthly use on mild to moderate presentations.
A spokesperson for the company said: "The new claim for the weekly use of Advocate should give veterinary surgeons a more effective route to go down when dealing with more severe cases, compared to monthly use. However, demodicosis is a complex condition which presents the practitioner with many challenges. So, from past experience with this condition, we would urge vets to be patient and also recognise the importance of treating any underlying disease process likely to exacerbate the situation."
Advocate Spot-on Solution has also been recently licensed for the prevention of Angiostrongylus vasorum, and the treatment of Crenosoma vulpis.
For further information, please contact your Bayer representative or the Bayer technical advice line on 0845 1305995.
Braving the elements, a record 12 candidates sat the examinations for the Certificate in Veterinary Practice Management last week, seven of which passed their selected elements, and four of which have been awarded their certificate.
The new CVPMs are, Julie Beacham at Wendover Heights Veterinary Centre in Aylesbury, Liz Howes at The Oxford Cat Clinic in Oxford, Helen Kington from Hungerford and Renay Rickard at the Pelyn Veterinary Group in Lostwithiel. An official presentation of the awards will take place at the Veterinary Practice Management Association Congress Dinner on 28th January 2010 at the Chesford Grange Hotel, Kenilworth, Warwickshire.
The candidates are managers in very different types of veterinary businesses, which the VPMA says is confirmation that the CVPM is applicable and has wide appeal in veterinary management.
Lucy Bartlett of CVS (UK) Ltd, Straight Mile Equine Clinic, Lisa Marter of The Arundel Equine Hospital and Steven Broomfield of The Blue Cross, were also successful in achieving a pass in the written and oral sections of the examination and will be able to complete the CVPM by submitting and passing the portfolio section of the exam next year.
There are now 61 holders of the CVPM since its inception in 1996. The next examination session will be held on 2nd December 2011.
45% of British pet owners believe their four legged friends share their human emotions and can sense when they are upset or unwell, according to a new survey announced by Bayer Animal Health.
The 'Pets are Human Too' study of 3,000 British dog and cat owners was commissioned by the company to celebrate Drontal's www.mypetsuperstar.com competition.
According to the study:
TV vet and My Pet Superstar Judge Emma Milne, said: "The joy and companionship our pets bring to our lives is unquestionable and it is no wonder that many consider them to be 'man's best friend'. Britain is a nation of proud pet owners and now, with the launch of My Pet Superstar, we all have a chance to show them off!"
Novartis Animal Health has announced that it will begin marketing and distributing Adequan Equine in the UK from January 2011.
According to the company, Adequan Equine offers equine veterinarians a proven intramuscular treatment option for equine degenerative joint disease, also known as non-infectious arthritis or osteoarthritis. The product is licensed in the UK for the treatment of lameness in horses due to traumatic or degenerative aseptic joint disease and acute superficial digital flexor tendonitis. This is a critical treatment area since equine degenerative joint disease is estimated to cause up to one-third of all equine lameness cases1. It most commonly affects the hocks and coffin joints with the most severe effects on the high-motion knee and fetlock joints.
Esther Rawlinson MRCVS, Global Technical Services Manager for the Novartis Animal Health Companion Animal Business in the Therapeutics & Equine areas said: "Adequan Equine is a leading joint treatment for horses and is widely used by veterinarians in the equine sport industry. Adequan Equine reduces pain and lameness in horses while at the same time stimulating cartilage repair.
Adequan Equine 100mg/ml solution contains polysulphated glycosaminoglycan for intramuscular injection. It is a chondroprotective, meaning it inhibits the breakdown of cartilage in diseased joints while at the same time supporting its repair.
Adequan Equine works by blocking the destructive enzymes formed in the joint as a result of inflammation while stimulating the production of hyaluronic acid to restore the synovial fluid, and the synthesis of cartilage building compounds.
Vetoquinol UK Limited has launched Kefloril, containing 300mg/ml florfenicol for use in cattle and pigs in 100ml and 250ml vials.
In cattle, Kefloril is licensed for preventative and therapeutic treatment of respiratory tract infections. In pigs, Kefloril is licensed for the treatment of acute outbreaks of respiratory disease. Kefloril has the added benefit of traceability stickers which are attached to each vial, designed to make it easier and quicker to record and monitor on-farm usage.
Vetoquinol says the addition of Kefloril to its anti-infective domain provides a cost-effective treatment for respiratory cases this winter.
Vetoquinol UK Limited has launched Ceftiocyl: a ready-to-use formulation containing 50mg/ml ceftiofur for use in cattle and pigs.
In cattle, Ceftiocyl can be used for the treatment of respiratory disease, acute interdigital necrobacillosis and acute post-partum metritis. In pigs, Ceftiocyl is licensed for the treatment of respiratory disease. Ceftiocyl has the added benefit of traceability stickers which are attached to each vial making it easier and quicker to record and monitor on-farm usage.
Susan Mitchell, Large Animal Product Manager at Vetoquinol UK Ltd said, 'We are delighted to be expanding our large animal anti infective range offering. Marbocyl 10% has been used for acute mastitis in the dairy sector for many years, the addition of Ceftiocyl to our portfolio enables us to provide a cost-effective treatment for both metritis and lameness.'
1. Willshire, J.A. & Bell, N, J. (2009) An economic review of cattle lameness. Cattle Practice 17, 136-141.
The RCVS Disciplinary Committee has suspended a Kent veterinary surgeon from the Register for eight months after he was found guilty of dishonest certification.
At the outset of the hearing held on 14/15 December, Takeshi Okano, of Lakeview Veterinary Centre in Deal, Kent, admitted charges that, whilst acting as Official Veterinarian, he had signed a number of certificates when he knew that did not have all the information needed to do so.
On 23 June 2009, Mr Okano had been asked to act as Official Veterinarian to examine four horses and sign the certificates necessary for their export to the USA. The certificates required Mr Okano to certify he had received a written declaration from the owners that the animals had been in the UK for 60 days previously. Mr Okano also signed certificates indicating that the horses had only been in France, Ireland, or the UK for the same 60-day period. Despite having received no such declarations, and having no information whatsoever of where the horses had been, Mr Okano signed the certificates. At the hearing, no explanation for Mr Okano's actions was offered.
Mrs Beverley Cottrell, Chairman of the Disciplinary Committee said: "The validity of any certificate is an integral part of the system relating to the export or import of animals. At Section G of the RCVS Guide to Professional Conduct, emphasis is given to the importance of certification, the importance of the signature and the guidance issued by DEFRA. These provisions are well known to the profession."
The Committee was satisfied that Mr Okano's actions in signing the certificates without the owners' declarations amounted to a serious departure from professional standards. In reaching a decision on sanction, it considered that, whilst a reprimand or warning would not be appropriate, neither would removing Mr Okano's name from the Register be proportionate, or necessary either in the public interest or to protect animals.
"Mr Okano is a young veterinary surgeon at the start of his career, who from the outset admitted his actions," said Mrs Cottrell noting that the testimonials from veterinary surgeons, veterinary nurses and clients, and his record of Continuing Professional Development demonstrated his commitment to high standards within the profession. "In reaching this decision, we have paid particular regard to the fact the false certification was neither persistent nor concealed, nor was he a senior veterinary surgeon."
The Committee directed Mr Okano's name be suspended from the Register for eight months.
Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.
Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.
Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future. I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed."
Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org
With dysentery apparently at its highest level for many years, Pfizer Animal Health has launched a new campaign to help increase awareness of the benefits of selecting the best prevention and treatment options.
Nigel Lodge MRCVS, Pfizer technical manager said: "The increase in dysentery can be attributed to a combination of factors including more frequent movement of weaners and a reduction in the level of feed medication resulting from the increasing use of more vaccines against other disease.
"With the early onset of winter, we know that dysentery will survive outside the pig for up to seven weeks in cold moist conditions and other pathogens for considerably longer."
The campaign is headed by a new guide, 'Enteric Disease Management', which looks at prevention and treatment of the problem, one of the most costly to the producer. Dysentery alone is estimated to cost more than £10 / pig finished considering higher mortality, increased feed costs and non-marketable animals.
The guide says that according to the housing system some of the pathogens have extremely long survival times - three months for E coli, nine months for salmonella and one year for coronavirus (transmissible gastroenteritis). It provides advice on limiting infection and reducing stress on the pigs.
Mr Lodge says that the incidence of dysentery fluctuates in different areas of the country with varying antibiotic sensitivity. Hence, a sensitivity test is essential when deciding on a particular medication.
With enteric diseases in general, there are a wide range of causes - including bacteria, viruses, parasites, management or nutrition. Mr Lodge said: "The causal agent can sometimes be diagnosed from clinical signs, such as dysentery, but generally post mortem and laboratory diagnosis is required.
"There are various antibiotic products which can be used but all should only be used after management issues such as bio security, pen management and rodent control have been addressed.
"Some products are specific in their activity, such as Lincocin Premix and swine dysentery. Others have a broad spectrum of activity and should be used where mixed infections are diagnosed. Linco-Spectin Premix, for instance, is active against E coli, Salmonella, ileitis, swine dysentery and other enteric bacteria."
Copies of the new publication - including a competition to win two prizes of one tonne of pig feed - are available from Pfizer Animal Health via Scott Wheway Tel: 01737 330941 or scott.a.wheway@pfizer.com
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2010 until 31st March 2011 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
According to the company, data from the Barren EweCheck and FlockCheck 2010 schemes showed that 86% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
The company anticipates full availability of Toxovax in 2011 and says its Barren EweCheck blood sample submission pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
Hill's Pet Nutrition is offering veterinary surgeons, vet students and nurses in the UK an opportunity to look round its Pet Nutrition Centre in Topeka, Kansas, via a live webcast to be delivered at 7pm on Tuesday 11th January 2011.
To join the webcast, which will last around 1.5 hours, go to http://www.fc-tv.com/webcast/keystone/hills/jan-11-11 and enter the password pnctour. This event is specifically for veterinary surgeons, veterinary students and veterinary nurses only.
Tim Dobbins, Associate Veterinary Affairs Manager said: "We look forward to our colleagues joining us for this special live webcast and hearing some of the latest thinking that explains the science behind some of our most exciting products."
Veterinary surgeons Lewis Grant and Professor Quintin McKellar have joined Dr Lydia Brown in the New Year's Honours List.
Mr Grant, former veterinary manager in the Meat Hygiene Service, Food Standards Agency and animal welfare representative of the Veterinary Public Health Association (VPHA) was awarded an MBE. Professor Quintin McKellar, Principal of the Royal Veterinary College has been awarded a CBE for services to science.
BVA Honorary Member the Earl of Selborne was also recognised with a GBE for services to science.
Harvey Locke, President of the BVA, said: "On behalf of the BVA I would like to congratulate Dr Brown, Lewis Grant, Professor McKellar and Lord Selborne on their fantastic achievements. These national honours underline the importance of veterinary medicine."
In contrast to the British Veterinary Association, The National Office of Animal Health (NOAH) has welcomed the decision by DEFRA not to proceed with the proposal contained in the draft Veterinary Medicines Regulations 2010 to prohibit the advertising of antimicrobials to farmers.
NOAH says it believes the proposal would have had a negative effect on farmers' ability to maintain their knowledge and awareness of animal health and welfare issues, and did not believe that it would reduce antimicrobial resistance profiles.
NOAH chief executive Phil Sketchley said: "Farmers, as professional producers of food, need to be kept well briefed on the antimicrobials they use, following prescription by their veterinary surgeons. Promotion by our members plays a key role in this and in educating farmers about animal welfare and disease."
NOAH members follow rigid rules on advertising and promotion through the longstanding Code of Practice for the Promotion of Animal Medicines.
Phil added: "The NOAH Code already goes beyond the Veterinary Medicines Regulations and is reviewed each year - this year we will be particularly looking to ensure that it fully reflects the industry's commitment to disease education and information on responsible use, particularly in relation to antimicrobial promotion. We have planned, at our Code review meeting in February, further discussions within NOAH and with the VMD to finalise how this can best be achieved.
"Importantly we must always remember that antimicrobial medicines for all animals are POM-V, meaning they have to be prescribed by a veterinary surgeon, and therefore it should be the vet who makes the decision on whether an antibiotic is needed. If such therapy is indicated, the most appropriate antibiotic for an animal or group of animals is selected by the veterinary surgeon based on the clinical signs shown, the current disease situation on the farm and in the area and where appropriate and feasible, is based on bacterial culture and sensitivity testing."
Using promotion to encourage responsible use, NOAH launched its 'Use Medicines Responsibly' campaign in 2009. A recommendation was made that members include a strap line on promotional material advising users to 'use medicines responsibly'.
NOAH was a founder member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and continues to be a strong contributor to and supporter of RUMA's communications to farmers including the antimicrobial guidelines. These guidelines are not intended to influence the veterinary surgeon's decision to prescribe but help support ways that the veterinary surgeon and farmer can work together to reduce the need to prescribe antimicrobials whilst ensuring they are used responsibly once prescribed in line with the principle of 'as little as possible but as much as necessary'.
Phil said: "Antibiotics are essential for the health and welfare of the UK's livestock population. NOAH accepts that antimicrobial resistance is a serious and growing subject of discussion for the medical and veterinary professions and we need to continue to take this matter seriously."
From 2 April - 2 May, National Pet Month will be encouraging people to get happy and healthy spending time with their pets, with its theme of 'Happiness is... time with your pet'.
Organisers say that during the month, thousands of people will be celebrating happy times with their pets at hundreds of events up and down the country. While many of these events will raise funds for local animal charities, National Pet Month is not just about fund raising. It is also all about raising awareness of how pets make people's lives happier and healthier, and how they can repay the pets they love by looking after them responsibly.
Veterinary practices can get involved in National Pet Month, and show what they have to offer clients and potential clients. Details of how to join in and become a supporter are on the website http://www.nationalpetmonth.org.uk/.
Last year's National Pet Month was apparently the most successful to date, with a record number of 1200 events and nearly £80,000 raised for at least 30 animal charities.
The 2010 overall best National Pet Month event was held by St Boniface Vets in Crediton, Devon. They participated by visiting local nursery and primary schools teaching children about pet health, and specifically raising awareness of exotic animals as pets. Phil Sketchley, Chairman of NPM said: "The 14 excellent educational visits that St Boniface made to local schools and nurseries were inspirational. They were a fantastic example of the partnerships that can be forged between practices and the community during National Pet Month."
He added: "School visits are one great way for practices to get involved - but there are many more. Our top veterinary practice 2010 event, for example, was held by Mill House Vets in Kings Lynn, and which focussed on educating owners on caring for older pets. National Pet Month is an opportunity to help your clients learn more about responsible pet care so they can enjoy their pets for many years to come."
Dechra Veterinary Products has launched a new Instruments and Consumables catalogue for veterinary professionals. The new catalogue is available to view online or download via Dechra's website at www.dechra.com
The new catalogue features the range of instruments and consumables available from Dechra, including a new wound dressing Silflex. This dressing is an atraumatic soft silicone contact layer, which minimises trauma at dressing change and protects delicate skin. Other products include Activon Medical Grade Manuka Honey dressings, Portex Jacksons cat catheters, Surgivet Slippery Sam cat catheters, ET tubes and 3M Vetrap bandaging tape.
The Dechra catalogue also includes help and advice for veterinary professionals, including step-by-step instructions for using some products and case studies for the range of wound dressings.
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
Equine vets and farriers in South Wales who need horses x-rayed can now use a new mobile service offered by Equiray. Operating 24 hours a day, 7 days a week, Equiray's technicians travel to the site to take digital x-rays, using state-of-the-art imaging equipment.
At the heart of Equiray's service is the Uno Equine portable digital x-ray system; the only system in the world that has a capture screen built into the generator. All images taken can be viewed within minutes and decisions made there and then regarding further tests. The x-ray images are emailed to the veterinary surgeon immediately, or supplied to the practice on a CD or memory stick. They are also stored securely by Equiray for a 3 month period.
For farriers, the image can be displayed on screen so they can see the internal bone structures encapsulated within the hoof before they start remedial work, and then another x-ray taken after the work has been completed. Both images can be viewed together for comparison.
Equiray says its service means practices don't have to buy and maintain costly equipment, nor send a practice technician to attend with the vet, as all Equiray technicians are highly skilled in equine imaging.
Equiray currently operates mainly in South Wales but with requests coming from other areas of the country, the company says its technicians are travelling to x-ray several horses in a particular area, over a 2 day period. Remedial farriers requiring monthly x-rays of certain horses are also using the service and plans to extend the service nationally are in progress.
For more information, visit www.equiray.co.uk/